Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana S Leal

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Theranostics|September 20, 2019
A nano-liposome formulation of the PARP inhibitor Talazoparib enhances treatment efficacy and modulates immune cell populations in mammary tumors of BRCA-deficient miceDi Zhang, Paige Baldwin, Ana S Leal, et al.
Advances in Pharmacology (San Diego, Calif.)|June 8, 2021
Potential therapeutic uses of rexinoidsAna S Leal, Lyndsey A Reich, Jessica A Moerland, et al.
Molecules and Cells|March 30, 2023
The Multi-Faceted Consequences of NRF2 Activation throughout CarcinogenesisChristopher J Occhiuto, Jessica A Moerland, Ana S Leal, et al.
Scientific Reports|October 31, 2018
Dehydroabietic oximes halt pancreatic cancer cell growth in the G1 phase through induction of p27 and downregulation of cyclin D1Laura E Kolsi, Ana S Leal, Jari Yli-Kauhaluoma, et al.
Biomedicines|January 28, 2026
RXR Agonist V-125 Induces Distinct Transcriptional and Immunomodulatory Programs in Mammary Tumors of MMTV-Neu Mice Compared to BexaroteneAfrin Sultana Chowdhury, Lyndsey A Reich, Karen T Liby, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 17, 2017
Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762Di Zhang, Ana S Leal, Sarah Carapellucci, et al.
Scientific Reports|May 10, 2019
The Rho/MRTF pathway inhibitor CCG-222740 reduces stellate cell activation and modulates immune cell populations in Kras<sup>G12D</sup>; Pdx1-Cre (KC) miceAna S Leal, Sean A Misek, Erika M Lisabeth, et al.
Natural Product Reports|October 11, 2012
Ursane-type pentacyclic triterpenoids as useful platforms to discover anticancer drugsJorge A R Salvador, Vânia M Moreira, Bruno M F Gonçalves, et al.
Beilstein Journal of Organic Chemistry|March 17, 2012
Efficient oxidation of oleanolic acid derivatives using magnesium bis(monoperoxyphthalate) hexahydrate (MMPP): A convenient 2-step procedure towards 12-oxo-28-carboxylic acid derivativesJorge A R Salvador, Vânia M Moreira, Rui M A Pinto, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 17, 2017
A BET Bromodomain Inhibitor Suppresses Adiposity-Associated Malignant TransformationDebrup Chakraborty, Vanessa Benham, Vladislav Jdanov, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Theranostics|September 20, 2019
A nano-liposome formulation of the PARP inhibitor Talazoparib enhances treatment efficacy and modulates immune cell populations in mammary tumors of BRCA-deficient miceDi Zhang, Paige Baldwin, Ana S Leal, et al.
Advances in Pharmacology (San Diego, Calif.)|June 8, 2021
Potential therapeutic uses of rexinoidsAna S Leal, Lyndsey A Reich, Jessica A Moerland, et al.
Molecules and Cells|March 30, 2023
The Multi-Faceted Consequences of NRF2 Activation throughout CarcinogenesisChristopher J Occhiuto, Jessica A Moerland, Ana S Leal, et al.
Scientific Reports|October 31, 2018
Dehydroabietic oximes halt pancreatic cancer cell growth in the G1 phase through induction of p27 and downregulation of cyclin D1Laura E Kolsi, Ana S Leal, Jari Yli-Kauhaluoma, et al.
Biomedicines|January 28, 2026
RXR Agonist V-125 Induces Distinct Transcriptional and Immunomodulatory Programs in Mammary Tumors of MMTV-Neu Mice Compared to BexaroteneAfrin Sultana Chowdhury, Lyndsey A Reich, Karen T Liby, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 17, 2017
Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762Di Zhang, Ana S Leal, Sarah Carapellucci, et al.
Scientific Reports|May 10, 2019
The Rho/MRTF pathway inhibitor CCG-222740 reduces stellate cell activation and modulates immune cell populations in Kras<sup>G12D</sup>; Pdx1-Cre (KC) miceAna S Leal, Sean A Misek, Erika M Lisabeth, et al.
Natural Product Reports|October 11, 2012
Ursane-type pentacyclic triterpenoids as useful platforms to discover anticancer drugsJorge A R Salvador, Vânia M Moreira, Bruno M F Gonçalves, et al.
Beilstein Journal of Organic Chemistry|March 17, 2012
Efficient oxidation of oleanolic acid derivatives using magnesium bis(monoperoxyphthalate) hexahydrate (MMPP): A convenient 2-step procedure towards 12-oxo-28-carboxylic acid derivativesJorge A R Salvador, Vânia M Moreira, Rui M A Pinto, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 17, 2017
A BET Bromodomain Inhibitor Suppresses Adiposity-Associated Malignant TransformationDebrup Chakraborty, Vanessa Benham, Vladislav Jdanov, et al.
Pageof 3